NCT02155205View on ClinicalTrials.gov

A Thorough QT Study of Telotristat Etiprate

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Conditions
QT Interval
Interventions
DRUG

Telotristat etiprate

1500 mg telotristat etiprate (six 250 mg tablets)

DRUG

Placebo

Matching placebo

DRUG

Moxifloxacin

400 mg moxifloxacin (one 400 mg tablet)

Trial Locations (1)

47710

Lexicon Investigational Site, Evansville

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY